Most cited article - PubMed ID 17957227
Sex-specific interaction between APOE and APOA5 variants and determination of plasma lipid levels
Familial hypercholesterolemia (FH) is one of the most common monogenic diseases, leading to an increased risk of premature atherosclerosis and its cardiovascular complications due to its effect on plasma cholesterol levels. Variants of three genes (LDL-R, APOB and PCSK9) are the major causes of FH, but in some probands, the FH phenotype is associated with variants of other genes. Alternatively, the typical clinical picture of FH can result from the accumulation of common cholesterol-increasing alleles (polygenic FH). Although the Czech Republic is one of the most successful countries with respect to FH detection, approximately 80% of FH patients remain undiagnosed. The opportunities for international collaboration and experience sharing within international programs (e.g., EAS FHSC, ScreenPro FH, etc.) will improve the detection of FH patients in the future and enable even more accessible and accurate genetic diagnostics.
- Keywords
- epidemiology, familial hypercholesterolemia, gene score, polygenic FH, variants,
- Publication type
- Journal Article MeSH
- Review MeSH
Apolipoprotein A5 (APOA5) is a small protein, expressed predominantly in the liver. In plasma, it is located on triglyceride rich lipoprotein particles (chylomicrones and VLDL) and on HDL. Plasma concentration of apolipoprotein A5 is very low, suggesting rather regulatory (activation of lipoprotein lipase, …) than structural function. APOA5 is an important determinant of plasma triglyceride concentration; this effect has been confirmed both on animal models, as well as on human studies. Minor alleles of three commonly analysed variants within this gene (rs662799, rs3135506, rs2075291) are associated with higher plasma TG values and increased risk of myocardial infarction, with some important interethnic differences observed. Further roles of APOA5; determination of BMI, diabetes and last but not least nutri- and pharmaco-genetic interactions are suggested, but without the definitive conclusions.
- Keywords
- Apolipoprotein A5, Cardiovascular disease, Polymorphism, Triglycerides,
- MeSH
- Apolipoprotein A-V blood genetics metabolism MeSH
- Polymorphism, Single Nucleotide * MeSH
- Cardiovascular Diseases blood epidemiology genetics MeSH
- Humans MeSH
- Triglycerides blood MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- APOA5 protein, human MeSH Browser
- Apolipoprotein A-V MeSH
- Triglycerides MeSH